DIVISLABS - Matched 200 ema.
Watch how the price was falling however RSI was flat all this time.
Stock now matched the 200 ema.
Good risk reward entrant for pharma sector.
Watch how the price was falling however RSI was flat all this time.
Stock now matched the 200 ema.
Good risk reward entrant for pharma sector.
Penafian
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Penafian
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.